法国非霍奇金淋巴瘤患者的生活条件 (LymphoVie 2)
This is an innovative project, allowing to study for the first time the long-term living conditions of patients after diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) from population data in France. Patients will be selected from the three specialized hematology registries in France: Côte-d'Or, Gironde and Basse-Normandie.
This is also one of the first studies to look at epidemiological indicators of net survival after diagnosis of follicular lymphoma and diffuse large B-cell lymphoma, adjusted for clinical factors such as disease stage, therapeutic management, and comorbidities, apart from the standard adjustment factors of age, sex, and time of diagnosis in real life. In addition, the proportion of cured patients will be estimated.
For component 1, this will be the survival analysis on the initial data. For part 2, questionnaires will be sent out followed by a follow-up if necessary one month after the mailing. There is no physical interview nor any specific biological or imaging examination.
研究概览
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Dijon、法国
- Chu Dijon Bourgogne
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients with non-Hodgkin's lymphoma
描述
Inclusion Criteria:
- Diagnosis period 2010-2018, according to the 2008 WHO ICD-O-3 classification, from the hematological malignancy registries of Côte-d'Or, Gironde, Basse-Normandie
- Patients with a diagnosis of follicular lymphoma (9690/3, 9691/3, 9695/3, 9698/3, 9597/3)
- Patients with a diagnosis of diffuse large B-cell lymphoma (9678/3, 9679/3, 9680/3, 9684/3, 9688/3, 9712/3, 9735/3, 9737/3, 9738/3)
- For Part 2: Individuals alive at the date of vital status update
Non-inclusion criteria:
- Other forms of malignant hemopathies at diagnosis,
- Minors.
Exclusion Criteria:
- Person under a legal protection measure (curatorship, guardianship)
- Person under a legal protection measure (guardianship, tutorship)
- Pregnant, parturient or breastfeeding women
- Major incapable or unable to express his consent
- Person who did not return the questionnaires following the 1-month follow-up, or patient who expressed refusal to participate.
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Part 1: Patients diagnosed with non-Hodgkin's lymphoma
Diagnosis period 2010-2018, from the hematological malignancy registries of Côte-d'Or, Gironde, Basse-Normandie |
Data from hematological malignancy registries |
|
Part 2: Patients diagnosed with live non-Hodgkin's lymphoma after vital status update
Update of vital status in December 2022 |
9 questionnaires were sent out:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Progression-free survival
大体时间:December 2022
|
Update of vital status (part 1) |
December 2022
|
|
Generic SF-12 questionnaire
大体时间:October 2024
|
Mesure of the quality of life (part 2) |
October 2024
|
|
Specific QLQ-C30 questionnaire
大体时间:October 2024
|
Mesure of the quality of life (part 2) |
October 2024
|
合作者和调查者
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.